Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
23,07 USD | +7,60% | +0,17% | +6,76% |
Omzet 2024 * | 31,42 mln. 29,13 mln. | Omzet 2025 * | 121 mln. 112 mln. | Marktkapitalisatie | 1,96 mld. 1,82 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -312 mln. -289 mln. | Nettowinst (verlies) 2025 * | -251 mln. -233 mln. | EV/omzet 2024 * | 53,1 x |
Nettoliquiditeiten 2024 * | 291 mln. 270 mln. | Nettoliquiditeiten 2025 * | 223 mln. 206 mln. | EV/omzet 2025 * | 14,3 x |
K/w-verhouding 2024 * |
-6,18
x | K/w-verhouding 2025 * |
-8,29
x | Werknemers | 184 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 98,24% |
Recentste transcriptie over Syndax Pharmaceuticals, Inc.
1 dag | +7,60% | ||
1 week | +0,17% | ||
Lopende maand | -1,58% | ||
1 maand | -5,49% | ||
3 maanden | +6,46% | ||
6 maanden | +52,48% | ||
Lopend jaar | +6,76% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Michael Metzger
CEO | Chief Executive Officer | 53 | 05-05-15 |
Peter Ordentlich
FOU | Founder | 55 | 11-10-05 |
Neil Gallagher
PSD | President | - | 10-04-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Keith Katkin
BRD | Director/Board Member | 52 | 29-03-17 |
Dennis Podlesak
CHM | Chairman | 66 | 01-12-08 |
Pierre Legault
BRD | Director/Board Member | 63 | 04-01-17 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.12% | 0 M€ | 0,00% | - | |
0.12% | 0 M€ | 0,00% | - | |
0.08% | 2 M€ | -.--% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
27-03-24 | 23,07 | +7,60% | 1 190 999 |
26-03-24 | 21,44 | -4,46% | 1 248 893 |
25-03-24 | 22,44 | -0,62% | 825 478 |
22-03-24 | 22,58 | -1,31% | 1 076 996 |
21-03-24 | 22,88 | -0,65% | 1 449 923 |
uitgestelde koers Nasdaq, 27 maart 2024 om 21:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+6,76% | 1,96 mld. | |
+9,16% | 45,97 mld. | |
+53,24% | 43,93 mld. | |
+11,20% | 42,34 mld. | |
-8,59% | 28,27 mld. | |
+16,40% | 27,18 mld. | |
-19,34% | 19,44 mld. | |
+13,95% | 13,83 mld. | |
+31,56% | 12,4 mld. | |
+10,63% | 11,45 mld. |